Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-acetamidobenzenesulfonamide
2. 121-61-9
3. N-(4-sulfamoylphenyl)acetamide
4. Acetylsulfanilamide
5. P-sulfamylacetanilide
6. Neotherapol
7. Erytrin
8. 4'-sulfamylacetanilide
9. N4-acetsulfanilamide
10. 4-acetylaminobenzenesulfonamide
11. 4'-sulfamoylacetanilide
12. Sulfanilamide-n4-acetate
13. N'-acetylsulphanilamide
14. 4'-sulphamoylacetanilide
15. P-sulfamoylacetanilide
16. P-(acetylamino)benzenesulfonamide
17. P-acetamidobenzenesulfonamide
18. Acetanilide, 4'-sulfamoyl-
19. Benzenesulfonamide, 4-(acetylamino)-
20. Benzenesulfonamide, P-acetamido-
21. N-(4-sulphamoylphenyl)acetamide
22. N-4-acetylsulfanilamide
23. Nsc 217
24. N(sup 4)-acetsulfanilamide
25. Acetamide, N-[4-(aminosulfonyl)phenyl]-
26. N(sup 4)-acetylsulfanilamide
27. N-(4-(aminosulfonyl)phenyl)acetamide
28. N-(4-sulfamylphenyl)acetamide
29. Ccris 6813
30. Sulfanilamide-n(sup 4)-acetate
31. Einecs 204-486-7
32. Brn 0746675
33. Acetamide, N-(4-(aminosulfonyl)phenyl)-
34. Dtxsid4041529
35. Ai3-08023
36. Nsc-217
37. N-[4-(aminosulfonyl)phenyl]acetamide
38. 340484wz3l
39. Nsc-406839
40. N4-acetyl Metabolite
41. Acetylsulfanilamide, N4-
42. Dtxcid2021529
43. Pkofbdhytmyvgj-uhfffaoysa-
44. N4-acetylsulfanilamide [mi]
45. Sulfacetamide Sodium Impurity B [ep Impurity]
46. Sulfacetamide Sodium Impurity B (ep Impurity)
47. Refchem:831615
48. Acetamide, N-(4-(aminosulfonyl)phenyl)-(9ci)
49. Inchi=1/c8h10n2o3s/c1-6(11)10-7-2-4-8(5-3-7)14(9,12)13/h2-5h,1h3,(h,10,11)(h2,9,12,13)
50. Mfcd00035784
51. A-319
52. N-[4-(aminosulf
53. Chembl687
54. P-acetylaminobenzenesulfonamide
55. Acetsulfanilamide
56. Unii-340484wz3l
57. N-(4-sulfamoyl-phenyl)-acetamide
58. N4 -acetylsulfanilamide
59. Enamine_001217
60. Cambridge Id 5152132
61. Oprea1_094374
62. Oprea1_582774
63. 4-acetamido-benzenesulfonamide
64. Schembl359721
65. Aromatic Sulfonamide Compound 8
66. Nsc217
67. Orb1298767
68. Schembl4499888
69. 4-n-acetylaminophenylsulfonamide
70. Bdbm16643
71. Aniline, N'-acetyl-4-sulphamoyl-
72. Hms1397h07
73. Aaa12161
74. Tox21_300850
75. Ebc-03489
76. Nsc406839
77. Sbb016985
78. Stl308440
79. Akos000141336
80. Msk4062-1000m
81. Acetamide, N-(4-aminosulfonylphenyl)-
82. Hy-w069721
83. Ps-4449
84. Sdccgmls-0064665.p001
85. N-[4-(aminosulfonyl)phenyl]acetamide #
86. Ncgc00248191-01
87. Ncgc00254753-01
88. Cas-121-61-9
89. Sy081511
90. Db-061940
91. A0115
92. Cs-0080221
93. Ns00011892
94. St50168205
95. En300-15532
96. F432395
97. P-sulfamylacetanilide Solution In Methanol, 1000ug/ml
98. Q27256303
99. Z27682721
| Molecular Weight | 214.24 g/mol |
|---|---|
| Molecular Formula | C8H10N2O3S |
| XLogP3 | 0 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 97.6 |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 299 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
85
PharmaCompass offers a list of A-319 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right A-319 manufacturer or A-319 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred A-319 manufacturer or A-319 supplier.
A A-319 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of A-319, including repackagers and relabelers. The FDA regulates A-319 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. A-319 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A A-319 supplier is an individual or a company that provides A-319 active pharmaceutical ingredient (API) or A-319 finished formulations upon request. The A-319 suppliers may include A-319 API manufacturers, exporters, distributors and traders.
A-319 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of A-319 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right A-319 GMP manufacturer or A-319 GMP API supplier for your needs.
A A-319 CoA (Certificate of Analysis) is a formal document that attests to A-319's compliance with A-319 specifications and serves as a tool for batch-level quality control.
A-319 CoA mostly includes findings from lab analyses of a specific batch. For each A-319 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
A-319 may be tested according to a variety of international standards, such as European Pharmacopoeia (A-319 EP), A-319 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (A-319 USP).
